JAK2 and myeloproliferative neoplasm: In our study, the mutational landscape in MPN patients with monocytosis was not clearly different from JAK2-mutated CMML patients and frequently showed mutation in genes of the epigenetic machinery, the spliceosome and the RAS pathway, which is more similar to CMML as compared to PV.